Ethyl 1-(3-aminopropyl)-4-piperidinecarboxylate
- $362 - $538
- Product name: Ethyl 1-(3-aminopropyl)-4-piperidinecarboxylate
- CAS: 203664-62-4
- MF: C11H22N2O2
- MW: 214.3
- EINECS:
- MDL Number:MFCD12025841
- Synonyms:Ethyl 1-(3-aminopropyl)-4-piperidinecarboxylate;ETHYL 1-(3-AMINOPROPYL)PIPERIDINE-4-CARBOXYLATE;4-Piperidinecarboxylic acid, 1-(3-aminopropyl)-, ethyl ester
4 prices
Selected condition:
Brand
- AK Scientific
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number6879AD
- Product descriptionEthyl1-(3-aminopropyl)-4-piperidinecarboxylate
- Packaging500mg
- Price$538
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM309621
- Product descriptionEthyl1-(3-aminopropyl)piperidine-4-carboxylate 95%
- Packaging1g
- Price$424
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11168848
- Product descriptionEthyl1-(3-aminopropyl)piperidine-4-carboxylate 95+%
- Packaging1g
- Price$450
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number046229
- Product descriptionEthyl 1-(3-aminopropyl)-4-piperidinecarboxylate >95%
- Packaging500mg
- Price$362
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 6879AD | Ethyl1-(3-aminopropyl)-4-piperidinecarboxylate | 500mg | $538 | 2021-12-16 | Buy |
Chemenu | CM309621 | Ethyl1-(3-aminopropyl)piperidine-4-carboxylate 95% | 1g | $424 | 2021-12-16 | Buy |
Crysdot | CD11168848 | Ethyl1-(3-aminopropyl)piperidine-4-carboxylate 95+% | 1g | $450 | 2021-12-16 | Buy |
Matrix Scientific | 046229 | Ethyl 1-(3-aminopropyl)-4-piperidinecarboxylate >95% | 500mg | $362 | 2021-12-16 | Buy |
Properties
Boiling point :302.4±37.0 °C(Predicted)
Density :1.023±0.06 g/cm3(Predicted)
pka :10.44±0.10(Predicted)
Density :1.023±0.06 g/cm3(Predicted)
pka :10.44±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|